Circulating immune checkpoints predict heart failure outcomes

Circulating immune checkpoints predict heart failure outcomes

Abstract Aims There are limited data examining the role of immune checkpoint (IC) ligands in the pathophysiology of heart failure (HF). Therefore, we explore this in three HF animal models and in three different human cohorts (healthy, stable, and worsening HF). Methods and results Transcriptomic an...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Elles M. Screever, Laura I.E. Yousif, Javid J. Moslehi, Joe‐Elie Salem, Adriaan A. Voors, Herman H.W. Silljé, Rudolf A. deBoer, Wouter C. Meijers
Формат:	Өгүүллэг
Хэл сонгох:	English
Хэвлэсэн:	Wiley 2023-08-01
Цуврал:	ESC Heart Failure
Нөхцлүүд:	Immune checkpoints PD‐L1 PD‐L2 Galectin‐9 Heart failure
Онлайн хандалт:	https://doi.org/10.1002/ehf2.14304

Ижил төстэй зүйлс

Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study
-н: Douglas B. Johnson, зэрэг
Хэвлэсэн: (2019-05-01)

Checkpoint Inhibition in Myeloma: Opportunities and Challenges
-н: Federica Costa, зэрэг
Хэвлэсэн: (2018-09-01)

The role of immune checkpoints in cardiovascular disease
-н: Laura I. Yousif, зэрэг
Хэвлэсэн: (2022-10-01)

Enhancing cancer care with improved checkpoint inhibitors
-н: Vickram A S, зэрэг
Хэвлэсэн: (2024-10-01)

Checkmate with checkpoint inhibitors: New paradigm in immunotherapy
-н: Ruby Dhar, зэрэг
Хэвлэсэн: (2023-04-01)

Characterization of PD-1/PD-L1 Immune Checkpoint Expression in Osteosarcoma
-н: Kazuhiko Hashimoto, зэрэг
Хэвлэсэн: (2020-07-01)

Immune Checkpoint in Glioblastoma: Promising and Challenging
-н: Jing Huang, зэрэг
Хэвлэсэн: (2017-05-01)

Phytochemicals in Cancer Immune Checkpoint Inhibitor Therapy
-н: Juwon Lee, зэрэг
Хэвлэсэн: (2021-07-01)

Overview of the Cardiotoxicity Induced by PD-1/PD-L1 Immune Checkpoint Inhibitor in Critical Care
-н: Ruiting Li, зэрэг
Хэвлэсэн: (2021-06-01)

On Demand Biosensors for Early Diagnosis of Cancer and Immune Checkpoints Blockade Therapy Monitoring from Liquid Biopsy
-н: Sai Mummareddy, зэрэг
Хэвлэсэн: (2021-12-01)

PD-1/PD-L1 immune checkpoint inhibitors in glioblastoma: clinical studies, challenges and potential
-н: Tianrui Yang, зэрэг
Хэвлэсэн: (2021-02-01)

PD-L1 expression on malignant cells is no prerequisite for checkpoint therapy
-н: Jan Willem Kleinovink, зэрэг
Хэвлэсэн: (2017-04-01)

Epigenetic modifications of the immune-checkpoint genes CTLA4 and PDCD1 in non-small cell lung cancer results in increased expression
-н: Sebastian Marwitz, зэрэг
Хэвлэсэн: (2017-05-01)

Immune Checkpoint Inhibitors in Cancer Therapy
-н: Yavar Shiravand, зэрэг
Хэвлэсэн: (2022-04-01)

Research Progress on Cardiotoxicity of PD-1/PD-L1 Immune Checkpoint Inhibitors
-н: YU Lin, зэрэг
Хэвлэсэн: (2021-08-01)

The Role of Immune Checkpoint Inhibitors in Cancer Therapy
-н: Ahmed M. Basudan
Хэвлэсэн: (2022-12-01)

The role of immune checkpoint inhibitors in prostate cancer
-н: Gabriel Surdacki, зэрэг
Хэвлэсэн: (2019-03-01)

Editorial: The Roles of Checkpoint Inhibitors in Inflammatory Diseases
-н: Andreas von Knethen, зэрэг
Хэвлэсэн: (2021-10-01)

Activity and Safety of Immune Checkpoint Inhibitors in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis
-н: Alberto Bongiovanni, зэрэг
Хэвлэсэн: (2021-05-01)

Predictive Biomarkers of Immune Checkpoint Inhibitors-Related Toxicities
-н: Ya Xu, зэрэг
Хэвлэсэн: (2020-10-01)

Structural Characterization of a Macrocyclic Peptide Modulator of the PD-1/PD-L1 Immune Checkpoint Axis
-н: Edyta Zyla, зэрэг
Хэвлэсэн: (2021-08-01)

The Neonatal Innate Immune Response to Sepsis: Checkpoint Proteins as Novel Mediators of This Response and as Possible Therapeutic/Diagnostic Levers
-н: Emily Hensler, зэрэг
Хэвлэсэн: (2022-07-01)

Key questions about the checkpoint blockade-are microRNAs an answer?
-н: Mihnea Dragomir, зэрэг
Хэвлэсэн: (2018-06-01)

Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer
-н: Maria Georganaki, зэрэг
Хэвлэсэн: (2018-12-01)

Enhancement of anti-tumor efficacy of immune checkpoint blockade by alpha-TEA
-н: William L. Redmond, зэрэг
Хэвлэсэн: (2023-02-01)

The epigenetic immunomodulator, HBI-8000, enhances the response and reverses resistance to checkpoint inhibitors
-н: Reid P. Bissonnette, зэрэг
Хэвлэсэн: (2021-08-01)

Advances in immune checkpoint inhibitors for hepatocellular carcinoma
-н: Ji Won Han, зэрэг
Хэвлэсэн: (2021-09-01)

Immune Checkpoint Inhibitors: Ctla-4 and Pd-1/Pd-l1 in Immunotherapy
-н: Kübra KAHVECİ, зэрэг
Хэвлэсэн: (2019-12-01)

Radiation, Immune Checkpoint Blockade and the Abscopal Effect: A Critical Review on Timing, Dose and Fractionation
-н: Zachary S. Buchwald, зэрэг
Хэвлэсэн: (2018-12-01)

Safety and efficacy of PD-1/PD-L1 immune checkpoint inhibitors in patients with pre-treated advanced stage malignant mesothelioma: a systematic review and meta-analysis
-н: Amjad Zafar, зэрэг
Хэвлэсэн: (2024-11-01)

The impact of antibiotic use on clinical features and survival outcomes of cancer patients treated with immune checkpoint inhibitors
-н: Jiaxin Zhou, зэрэг
Хэвлэсэн: (2022-07-01)

Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
-н: Adel Naimi, зэрэг
Хэвлэсэн: (2022-04-01)

Editorial: Biomarkers of Immune-Checkpoint-Inhibitor Immunotherapies in Hepatocellular Carcinomas
-н: Zhanjun Guo, зэрэг
Хэвлэсэн: (2022-03-01)

Profiling targetable immune checkpoints in osteosarcoma
-н: Troy A McEachron, зэрэг
Хэвлэсэн: (2018-12-01)

The Use of Phytochemicals to Improve the Efficacy of Immune Checkpoint Inhibitors: Opportunities and Challenges
-н: Deniz Can Guven, зэрэг
Хэвлэсэн: (2022-10-01)

Commentary: Chronic PD-1 Checkpoint Blockade Does Not Affect Cognition or Promote Tau Clearance in a Tauopathy Mouse Model
-н: Kuti Baruch, зэрэг
Хэвлэсэн: (2020-05-01)

NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy
-н: Leona Raskova Kafkova, зэрэг
Хэвлэсэн: (2024-02-01)

Efficacy and safety of immune checkpoint inhibitors in non-small cell lung cancer
-н: Shuai Wang, зэрэг
Хэвлэсэн: (2018-08-01)

PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells
-н: Silvia Pesce, зэрэг
Хэвлэсэн: (2019-06-01)

In Search of Better Peptide-(Derived from PD-L2)-Based Immune Checkpoint Inhibitors
-н: Boris Klebansky, зэрэг
Хэвлэсэн: (2024-05-01)